Gastrax
Gastrax Brand names, Gastrax Analogs
Gastrax Brand Names Mixture
- No information avaliable
Gastrax Chemical_Formula
C12H21N5O2S2
Gastrax RX_link
http://www.rxlist.com/cgi/generic/nizat.htm
Gastrax fda sheet
Gastrax msds (material safety sheet)
Gastrax Synthesis Reference
R. P. Pioch, U.S. Pat. 4,375,547 (1982)
Gastrax Molecular Weight
331.46 g/mol
Gastrax Melting Point
203 oC
Gastrax H2O Solubility
10-33mg/mL
Gastrax State
Solid
Gastrax LogP
1.506
Gastrax Dosage Forms
Capsule (150, 300 mg)
Gastrax Indication
For the treatment of acid-reflux disorders (GERD), peptic ulcer disease, active benign gastric ulcer, and active duodenal ulcer.
Gastrax Pharmacology
Nizatidine is a competitive, reversible inhibitor of histamine at the histamine H2-receptors, particularly those in the gastric parietal cells. By inhibiting the action of histamine on stomach cells, nizatidine reduces stomach acid production. Nizatidine had no demonstrable antiandrogenic action. Full-dose therapy for the problems treated by nizatidine lasts no longer than 8 weeks. It has been demonstrated that treatment with a reduced dose of nizatidine is effective as maintenance therapy following healing of active duodenal ulcers.
Gastrax Absorption
Rapid (bioavailability of nizatidine exceeds 70%)
Gastrax side effects and Toxicity
Oral, rat LD50: 301 mg/kg. Symptoms of overdose include cholinergic-type effects including lacrimation, salivation, emesis, miosis, and diarrhea.
Gastrax Patient Information
Gastrax Organisms Affected
Humans and other mammals
